Previous 10 | Next 10 |
Reports preliminary fourth quarter 2023 revenue of $17.5 million WINTER SPRINGS, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in developing innovative Magnetic Resonance Imaging (‘MRI”) compatible m...
WINTER SPRINGS, Fla., Jan. 02, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in developing innovative Magnetic Resonance Imaging (“MRI”) compatible medical devices, today announced that the Company will be participating in the u...
2023-12-20 15:50:31 ET Summary Popular trades for 2024 include REITs, long-duration and high yield bond funds, small and mid-cap stocks, and dividend aristocrats. Peter Lynch's small-cap wish list includes low institutional ownership, a PEG ratio at or less than 1, a healthy balan...
2023-12-15 00:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-12 10:28:06 ET More on iRadimed IRadimed: Which Way Now IRadimed Corporation (IRMD) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on iRadimed Historical earnings data for iRadimed Financial information for iRadimed ...
WINTER SPRINGS, Fla., Dec. 12, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) announced today that its Board of Directors approved a special cash dividend of $0.48 per share and the initiation of a regular quarterly dividend on the Company's outstanding common stock....
WINTER SPRING, Fla., Nov. 30, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) was recently named on Forbes ’ latest list of America’s Most Successful Small-Cap Companies for 2024. Iradimed is a leader in the development of innovativ...
2023-11-06 15:14:48 ET Summary Today, we take our first look at a small medical device concern called IRadimed Corporation. The company is banking on continued demand for portable MRI devices and IV infusion pump replacement cycle to consistently power growth in the years ahead. ...
2023-11-03 13:30:22 ET IRadimed Corporation (IRMD) Q3 2023 Earnings Conference Call November 3, 2023 11:00 AM ET Company Participants Roger Susi - President and Chief Executive Officer Jack Glenn - Chief Financial Officer Conference Call Participants Scot...
2023-11-03 08:16:46 ET More on iRadimed IRadimed Continues Ploughing Along With Superb Economic Characteristics Seeking Alpha’s Quant Rating on iRadimed Historical earnings data for iRadimed Financial information for iRadimed For further detail...
News, Short Squeeze, Breakout and More Instantly...
2024-06-17 12:00:11 ET Frank Takkinen from Loop Capital Markets issued a price target of $60.00 for IRMD on 2024-06-17 09:49:00. The adjusted price target was set to $60.00. At the time of the announcement, IRMD was trading at $43.285. IRMD currently trades -15.48% versu...
2024-06-17 11:15:03 ET Lake Street analyst issues BUY recommendation for IRMD on June 17, 2024 09:49AM ET. The previous analyst recommendation was Buy. IRMD was trading at $43.285 at issue of the analyst recommendation. Historical Analyst Recommendations Latest 10 ...
WINTER SPRINGS, Fla., June 07, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices, announced today its common stock will uplist and commence trading on the Nasdaq Glo...